ZOLL gains US clearance for R series code-ready defibrillator with
WiFi option
8 January 2009
ZOLL Medical Corporation (Nasdaq GS: ZOLL) has received US FDA
clearance for its ZOLL R series code-ready clinical defibrillator with a
WiFi option that allows wireless communication between the defibrillator
and standard hospital networks to help ensure code-readiness and
download patient data.
Based on standard 802.11b WiFi technology, R Series defibrillators
equipped with WiFi automatically send an alert when their state of
readiness is compromised. Early notification maximizes patient safety by
letting the clinician intervene before the defibrillator is needed for a
code.
While defibrillators rarely fail, their readiness can be compromised
if someone forgets to plug it in, a cable is missing, or the electrodes
are old and dried out. With WiFi, when the state of readiness is
compromised, a notification identifies the contributing factors and code
readiness can be restored with unmatched efficiency by troubleshooting
from any PC on the hospital network.
For downloading patient data, the defibrillator summary is an
important part of the code, and the R series WiFi capability simplifies
merging the summary report with event documentation. At the end of the
code, the summary report can be transmitted over a standard wireless
network to a server hosting the CodeNet system, where it is merged and
time-synchronized with the Event Report documented on CodeNet Writer.
“Since defibrillators are widely distributed throughout hospitals,
and their use is both infrequent and extremely critical, ZOLL’s
technology helps ensure code readiness when they are needed for a code,”
said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL.
“Introducing technology that helps clinicians save more lives is what
ZOLL is about.”
Bookmark this page